Biogen Sells Samsung Bioepis Stake In $2.3bn Buyout

Samsung Biologics To Take Full Ownership Of Biosimilars Joint Venture

 
• By David Wallace
  
Samsung Biologics logo website magnifying glass
Samsung Biologics has taken control of the biosimilars joint venture • Source: Dennis Diatel / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Archive

More from Generics Bulletin